Is curing AIDS worth the risk?
1 Mins read
Reading Time: < 1 minute Scientific advances have put us closer than we’ve ever been to an end to AIDS. Read More
People living longer, though not healthier, with HIV, analysis finds
1 Mins read
Reading Time: < 1 minutePeople with HIV are living longer, and now have an average life expectancy that approaches that of those who did not have…
Could Gilead Sciences Have an HIV Cure Waiting in the Wings?
1 Mins read
Reading Time: < 1 minuteMost of the buzz over Gilead Sciences (NASDAQ: GILD) in recent months has centered on its antiviral drug remdesivir. Read More
Hitting HIV Hard in America: New Steps in Prevention
1 Mins read
Reading Time: < 1 minute As we head toward another US election season in 2020, access to health care remains a key issue in our country…
Exploring safe contraception methods for women living with HIV
1 Mins read
Reading Time: < 1 minuteWomen living with HIV need to know which contraceptive methods are safe for them Read More
Negative stereotypes of people with HIV/AIDS remain strong in Taiwan
1 Mins read
Reading Time: < 1 minuteOver 50 percent of people in Taiwan hold negative impressions of people infected with HIV (human immunodeficiency virus) and AIDS, Read More
Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016
1 Mins read
Reading Time: < 1 minute Question Is antiretroviral therapy associated with improved survival among individuals with HIV infection? Read More
There is a call on the government to expand HIV testing services in Ireland.
1 Mins read
Reading Time: < 1 minuteThere is a call on the government to expand HIV testing services in Ireland. Read More
13 Reasons Why star defends controversial AIDS storyline
1 Mins read
Reading Time: < 1 minute Dylan Minnette has defended the controversial AIDS storyline on 13 Reasons Why. Read More
Could Gilead Sciences Have an HIV Cure Waiting in the Wings?
1 Mins read
Reading Time: < 1 minuteMost of the buzz over Gilead Sciences (NASDAQ: GILD) in recent months has centered on its antiviral drug remdesivir. Read More